Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Dysregulation of mRNA translation can contribute to the development and progression of cancer whilst also having an impact on the prognosis of different types of malignancies. Eukaryotic translation initiation factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yan, Zhang, Ruihong, Li, Xiangrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889454/
https://www.ncbi.nlm.nih.gov/pubmed/36435920
http://dx.doi.org/10.1007/s11033-022-07917-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889454/
https://www.ncbi.nlm.nih.gov/pubmed/36435920
http://dx.doi.org/10.1007/s11033-022-07917-w

Ejemplares similares